Cortical Chauvinism

FDA Warns Against Unproven Autism Therapies

Treatments claiming to treat autism spectrum disorders such as chelation therapies, detoxifying clay baths, hyperbaric oxygen therapy, raw camel milk and essential oils are ineffective and may pose significant health risks, according to an updated FDA warning that reiterated the absence of cures for ASD. The FDA only recommends antipsychotics Abilify, or aripripazole, and Risperdal, or risperidone, with the specific purpose of treating autism-related irritability in children.  These drugs are usually given as a last resort and may have serious side effects for which they should be carefully monitored.

“Autism varies widely in severity and symptoms,” said Amy Taylor, a pediatrician at the FDA. “Existing autism therapies and interventions are designed to address specific symptoms and can bring about improvement.”

The following paragraphs are taken from an updated position statement by the FDA that was published in April 12, 2017. The US FDA news release can be found at: https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm394757.htm. The page has an application that allows the same to be translated in Spanish.

According to Commander Jason Humbert, M.H.S., R.N., a regulatory operations officer in the FDA’s Office of Regulatory Affairs, the agency has warned and/or taken action against a number of companies that have made improper claims about their products’ intended use as a treatment or cure for autism or autism-related symptoms. Some of these so-called therapies carry significant health risks and include:

Humbert offers some quick tips to help you identify false or misleading claims.